| Dr Pitt Vesom, MD | |
|
1149 Hickory Ridge Trl, Arnold, MO 63010-2760 | |
| (636) 282-1918 | |
| (636) 282-1918 |
| Full Name | Dr Pitt Vesom |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1149 Hickory Ridge Trl, Arnold, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073568150 | NPI | - | NPPES |
| 202104105 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 2003026274 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pitt Vesom, MD 1149 Hickory Ridge Trl, Arnold, MO 63010-2760 Ph: (636) 282-1918 | Dr Pitt Vesom, MD 1149 Hickory Ridge Trl, Arnold, MO 63010-2760 Ph: (636) 282-1918 |
News Archive
That snake heading towards you may be further away than it appears. Fear can skew our perception of approaching objects, causing us to underestimate the distance of a threatening one, finds a study published in Current Biology.
Viscus Biologics LLC, Cleveland, Ohio, has secured an 18-month option to conduct further research into the development and commercialisation of a new tissue repair material developed by the Network of Excellence for Functional Biomaterials (NFB) at National University of Ireland, Galway.
As health insurance moves to a direct-to-consumer model, identifying where consumers are located and what health plan options are available in local markets is essential. The Affordable Care Act is reshaping the industry and setting standards to ensure that consumers have coverage options in all geographies of every state in the U.S. Companies participating in the Marketplace (Exchanges) are using county market share and penetration rates to identify underinsured opportunities for Medicaid and Commercial market expansion.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of two clinical studies of TC-5619, a Phase 2b study evaluating the product candidate as a treatment for negative symptoms and cognitive dysfunction in schizophrenia and a Phase 2 study evaluating the product candidate in adults as a treatment for attention deficit/hyperactivity disorder (ADHD), inattentive-predominant.
› Verified 1 days ago
Dr. Abdul Rashid Qureshi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1314 Jeffco Blvd, # 458, Arnold, MO 63010 Phone: 314-843-3110 Fax: 314-843-0627 | |
Kurmanadha Chadalawada, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr, Suite 150, Arnold, MO 63010 Phone: 636-461-1414 Fax: 636-461-2013 | |
Dr. Keith Alan Georger, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18 Fox Valley Ctr, Arnold, MO 63010 Phone: 636-282-9899 Fax: 636-282-2279 | |
Dr. Sheryl Stanford Ream, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr., Suite 170, Arnold, MO 63010 Phone: 636-717-6776 Fax: 314-525-4055 |